Earnings History Data for PharmaCyte Biotech, Inc. (PMCB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-03-2022	??	PMCB	PharmaCyte Biotech, Inc.	43.09	-0.04	-0.05	0.00	PharmaCyte Biotech reports Q3 results [3/16/2022 9:23 AM]	0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0

14-12-2021	PM	PMCB	Nuvilex	52.00	-0.06	-0.07	0.00	PharmaCyte Biotech reports FQ2 results [12/15/2021 9:08 AM]	2.55	0.15 (6.12%)	2.43	0.03 (1.25%)	2.25 - 55.50	297,600	330,000	1,024
PharmaCyte Biotech reports FQ2 results [12/15/2021 9:08 AM] PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights [Dec-15-21 09:00AM]